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SUMMARY
We have used a human artificial chromosome (HAC)
to manipulate the epigenetic state of chromatin
within an active kinetochore. The HAC has a dimeric
a-satellite repeat containing one natural monomer
with a CENP-B binding site, and one completely
artificial synthetic monomer with the CENP-B box
replaced by a tetracycline operator (tetO). This HAC
exhibits normal kinetochore protein composition
and mitotic stability. Targeting of several tet-repres-
sor (tetR) fusions into the centromere had no effect
on kinetochore function. However, altering the chro-
matin state to a more open configuration with the tTA
transcriptional activator or to a more closed state
with the tTS transcription silencer caused missegre-
gation and loss of the HAC. tTS binding caused the
loss of CENP-A, CENP-B, CENP-C, and H3K4me2
from the centromere accompanied by an accumula-
tion of histone H3K9me3. Our results reveal that a dy-
namic balance between centromeric chromatin and
heterochromatin is essential for vertebrate kineto-
chore activity.
INTRODUCTION
In budding yeast, kinetochore assembly begins with the recogni-
tion of key DNA sequences by sequence-specific DNA-binding
proteins. The cloning of yeast centromere DNA and the subse-
quent development of artificial chromosomes (YACs; Murray
and Szostak, 1983) allowed detailed characterization of the pro-
tein and DNA components, so that the budding yeast has the
best-characterized of all kinetochores (Lechner and Carbon,
1991; Doheny et al., 1993). Other kinetochores remain less well
understood, partly because as first observed in S. pombe
(Steiner and Clarke, 1994; Ekwall et al., 1997), epigenetic effects
play a major role in centromere specification (Earnshaw and
Migeon, 1985; Alonso et al., 2003; Chueh et al., 2005).
The isolation of human artificial chromosomes (HACs) offers
a powerful way to study vertebrate kinetochore assembly.
HACs have been obtained in HT1080 human fibrosarcoma cells
using regular arrays of alphoid DNA derived from human centro-
meres (Harrington et al., 1997; Ikeno et al., 1998; Henning et al.,
1999; Ebersole et al., 2000; Grimes et al., 2001; Mejia et al.,
2001). HAC kinetochores accurately mimic the structure and mi-
totic behavior of endogenous kinetochores (Tsuduki et al., 2006).
The cloned alphoid DNA assembles into kinetochore-specific
chromatin with CENP-A (Sullivan and Karpen, 2001; Black
et al., 2004) and CENP-C (Saitoh et al., 1992), and carries core
histone modifications characteristic of centromeric chromatin
(Nakashima et al., 2005).
A specialized structure of kinetochore chromatin was first
shown for the central core of the S. pombe kinetochore (Takaha-
shi et al., 1992; Saitoh et al., 1997), which is flanked by hetero-
chromatin-like regions (Allshire et al., 1994; Partridge et al.,
2000). More recently, a novel form of chromatin termed ‘‘centro-
mere chromatin’’ in which CENP-A clusters are interspersed with
clusters of dimethylated histone H3 Lys4 (H3K4me2) has been
proposed for human, D. melanogaster, and rice centromeres
(Blower et al., 2002; Nagaki et al., 2004; Sullivan and Karpen,
2004), as well as a human neocentromeres (Chueh et al., 2005).
The goal of the present study was to establish a system per-
mitting manipulation of the epigenetic status of a single kineto-
chore in living cells. Prior attempts to manipulate centromere
chromatin have involved treatment of cells with chemical inhibi-
tors or protein overexpression and/or knockdowns. Such treat-
ments affect all centromeres, and may alter additional aspects
of cellular physiology as well. Here, we describe an HAC in which
the underlying alphoid DNA repeat contains a tetracycline re-
pressor (tetR) binding site (tetO). This enables us to target any
desired protein into the active kinetochore of the alphoidtetO
HAC as a tetR fusion protein. Our results reveal that kinetochore
activity appears to depend upon the status of the underlying
chromatin. We show that although introducing a transcriptional
activator into alphoid DNA can lead to centromere inactivation,
surprisingly, introducing a transcriptional repressor into the cen-
tromere has a much stronger effect, leading to the rapid and
quantitative loss of kinetochore function.
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RESULTS
HAC Formation Using a Synthetic Alphoid DNA Dimer
To obtain a human artificial chromosome (HAC) suitable for ma-
nipulation of the epigenetic status of the kinetochore, we de-
signed a novel artificial alphoidtetO dimer with one monomer
from a chromosome 17 alphoid 16-mer higher order repeat
(Waye and Willard, 1986) linked to a wholly synthetic alphoid
monomer based on a published consensus sequence (Choo
et al., 1991). The natural monomer contains a CENP-B binding
motif (CENP-B box; Masumoto et al., 1989). In the synthetic
monomer, this was replaced with a 42 bp tetracycline operator
(tetO), the binding site for E. coli tetracycline repressor (tetR)
(Figure 1A).
HAC formation in HT1080 cells requires input naked alphoid
DNA of at least 30 kb for functional CENP-A core assembly (Oka-
moto et al., 2007). The artificial alphoidtetO dimer cloned by con-
ventional means to 3.5 kb was further extended by rolling circle
amplification usingf29 phage DNA polymerase plus yeast trans-
formation-associated recombination (TAR) cloning (Figure 1B;
Ebersole et al., 2005). This yielded 50 kb of alphoidtetO dimeric re-
peat cloned head-to-tail in a BAC vector (BAC32-2-mer(tetO);
see Figure S1 in the Supplemental Data available with this article
online).
BAC32-2-mer(tetO) formed HACs when introduced into
HT1080 cells. FISH analysis of the transformants with probes
specific for alphoidtetO dimer or BAC sequences revealed
HACs in 2 of 46 transformant cell lines analyzed (Figure 1C and
Table S1A). Both the HAC formation efficiency (4.3%) and frac-
tion of HAC-containing cells (35.7% or 28.6%) in the two cell
lines were lower than control values obtained using a natural
alphoid DNA array (30% and > 50%, respectively, for a 60 kb
BAC containing wild-type chromosome 21 type I alphoid DNA
[alphoid11-mer]). The alphoidtetO HACs contained 16 or 48 copies
of the input DNA (Table S1B), and lacked host chromosomal
DNA detectable with inter- and intra-Alu PCR probes.
Subcloning of these two original cell lines yielded several cell
lines in which one copy of the HAC was maintained stably under
nonselective conditions (loss rate = 0.0024 or 0.0054, Table
S1B). Subsequent experiments were performed on alphoidtetO
HAC-containing cell line AB2.2.18.21. FISH analysis with the
BAC probe revealed that the HAC behaved normally during
mitosis (Figures 1D and 1E). Thus, despite the low HAC forma-
tion efficiency, the alphoidtetO HAC segregates correctly as an
independent chromosome.
Tetracycline Repressor and Centromere Proteins
Associate with AlphoidtetO Sequences
in the HAC Kinetochore
To test the ability of tetR to target the alphoidtetO array within the
active kinetochore, constructs expressing fluorescent proteins
(FP) fused to tetR (mRFP-tetR and tetR-EYFP) were transfected
into AB 2.2.18.21 cells. After expression for 24 hr, mRFP-tetR
showed a single bright focus in interphase nuclei (Figures
1F0 and 1G0). This was the HAC, as it colocalized with both
centromere and kinetochore markers, including CENP-B and
CENP-C (Figures 1F and 1G). A specific signal could also be
seen on the HAC in mitotic cells (Figure S2).
Immuno-FISH (Figure S3) confirmed that the HAC (detected
with the BAC probe) binds kinetochore proteins, including
CENP-A, CENP-C, and CENP-H (Warburton et al., 1997; Sugata
et al., 2000), as well as INCENP, a key subunit of the chromo-
somal passenger complex (Vagnarelli and Earnshaw, 2004).
Together, these results confirm that the alphoidtetO HAC
assembles a bona fide kinetochore that can be targeted with
tetR fusion proteins.
Several Different Chromatin Structures Form
on the AlphoidtetO HAC
Chromatin immunoprecipitation (ChIP) analysis confirmed that
the synthetic alphoidtetO monomers are located within the active
kinetochore on the HAC. Immunoprecipitation with antibodies to
CENP-A and CENP-B yielded an enrichment for the alphoidtetO
repeat comparable to that seen at control endogenous and
HAC centromeres (Figure 2A). Analysis of extended chromo-
some fibers revealed that CENP-A is distributed along the length
of the HAC, and is associated primarily with regions of
alphoidtetO sequence (Figure S4).
ChIP analysis revealed high levels of trimethylated histone H3
Lys4 (H3K4me3), a marker for transcriptionally active chromatin
(Jenuwein and Allis, 2001; Santos-Rosa et al., 2002; Schneider
et al., 2004), on the marker gene of the alphoidtetO HAC. Much
lower H3K4me3 levels were found on the alphoidtetO repeat itself
(Figure 2A). Consistent with this, trimethylated histone H3 Lys9
(H3K9me3), a marker for silent chromatin (Peters et al., 2003;
Guenatri et al., 2004), was associated with the alphoidtetO array
(Figure 2A), where it alternated with regions containing CENP-A
in extended HAC fibers (Figure S4). Similar results were obtained
with the 11-mer alphoid repeat of native chromosome 21
(alphoidchr. 21) and the alphoid11-mer repeat of the control
HAC (Figure 2A).
Figure 1. Isolation of the AlphoidtetO HAC
(A) Sequence comparison between the alphoid monomers used for the alphoidtetO DNA array and the alphoid consensus. One monomer of the alphoidtetO dimer is
derived from a chromosome 17 alphoid type I 16-mer unit and contains a CENP-B box (shaded green). The second monomer is a wholly synthetic sequence
derived from the Choo consensus (Choo et al., 1991), with sequences corresponding to the CENP-B box replaced by a 42 bp tetO motif (shaded blue). Other
bases that differ from the consensus are shaded in yellow.
(B) Diagram showing the construction of the alphoidtetO BAC by rolling circle amplification (RCA) in vitro and transformation-associated recombination (TAR) clon-
ing in yeast cells. This yielded BAC clone, BAC32-2-mer(tetO), containing 50 kb of the alphoidtetO dimer DNA.
(C) FISH analysis of a metaphase cell chromosome spread containing the alphoidtetO HAC (AB2.2.18.21) with alphoidtetO (green) and BAC vector probes (red).
Chromosomes were counterstained with DAPI (blue in merged panels). Endogenous chromosome 17 centromeres were also detected by the alphoidtetO probe
(arrows in upper panel).
(D and D0) FISH on AB 2.2.18.21 cells in metaphase (D) and anaphase (D0). Arrows indicate the HAC undergoing normal segregation.
(E) Cell in cytokinesis transfected with mRFP-TetR (red) and stained with anti-tubulin antibody (green) and DAPI (blue). mRFP-TetR binds to the HAC (arrows), in
the two daughter cells.
(F and G) mRFP-TetR binds to the alphoidtetO HAC in vivo where it colocalizes (arrows) with CENP-B (F), CENP-C (G) (both green), and DNA ([F00 and G00], blue).
Size bars in (D–G) = 5 mm.
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H3K4me2, a marker for transcriptionally competent or neutral
chromatin (Santos-Rosa et al., 2002; Schneider et al., 2004),
has recently been proposed to be a marker for centromere chro-
matin (Sullivan and Karpen, 2004; Schueler and Sullivan, 2006).
Indeed, regions containing H3K4me2 tended to alternate with re-
gions containing CENP-A in extended HAC fibers (Figure S4).
Figure 2. ChIP Analysis of CENP Assembly and Modified Histone H3 on Two Independent AlphoidtetO HACs
(A) PCR analysis of immunoprecipitates using antibodies against CENP-A, CENP-B, H3K4me2, H3K4me3, or H3K9me3. Chromatin was precipitated from three
HAC-containing cell lines: a control HAC with a 60 kb BAC array of chromosome 21 type I 11-mer alphoid DNA (alphoid11-mer) (left), or the independent
AB2.2.18.21 and AB2.5.4.19 sublines bearing the alphoidtetO HAC (middle and right, respectively). The bars show the relative rate of recovery of various target
DNA loci by immunoprecipitation with each antibody, calculated by dividing the percentage recovery of each DNA locus (as indicated) by that recovered in the
control IP with mouse normal IgG. Error bars indicate SD (n = 3). CENP-A and CENP-B associate preferentially with the alphoidtetO DNA, alphoid11-mer from the
wild-type control HAC, or endogenous alphoidchr. 21 relative to that seen with the marker genes, 5S ribosomal DNA and Sat2 (p < 0.05). The average recoveries of
alphoidtetO sequences by anti-H3K4me2 antibody were significantly higher than the recovery of the alphoid11-mer from the control HAC and alphoidchr. 21 (p < 0.05,
Student’s t test).
(B) AB2.2.18.21 cells bearing the alphoidtetO HAC and expressing tetR-EYFP were cultured in doxycycline-free medium for 7 or 14 d and analyzed by ChIP assay
with anti-GFP antibody. The bars show the relative enrichment of various target DNA loci by immunoprecipitation with anti-GFP antibody (binds the EYFP moiety
of tetR-EYFP). Error bars indicate SD (n = 2).
Developmental Cell
Conditional Human Centromere
510 Developmental Cell 14, 507–522, April 2008 ª2008 Elsevier Inc.
Developmental Cell
Conditional Human Centromere
Developmental Cell 14, 507–522, April 2008 ª2008 Elsevier Inc. 511
However, we found H3K4me2 associated with the alphoidtetO
repeat at levels significantly above those on alphoidchr. 21 or the
alphoid11-mer control HAC (Figure 2A). Thus, the alphoidtetO array
appears to form a slightly more open/neutral chromatin structure
than occurs at native centromeres. However, because the al-
phoidtetO and control HAC exhibit comparable high stability, these
subtle differences must not interfere with kinetochore function.
Direct binding of tetR-EYFP to the alphoidtetO array in
AB2.2.18.21 cells stably expressing tetR-EYFP fusion protein
was confirmed by ChIP analysis using anti-GFP antibody
(Figure 2B). A stable subline was isolated and maintained in me-
dium containing doxycycline (Dox) to inhibit tetR-EYFP binding
to the alphoidtetO array during selection and growth of the cells.
Anti-GFP antibody precipitated alphoidtetO DNA fragments only
after the cells were grown without doxycycline for 7 and 14 d (Fig-
ure 2B). Thus, targeting of the tetR to the alphoidtetO DNA in vivo
can be controlled by the presence or absence of doxycycline.
Binding of the tTA Transactivator Can Induce
AlphoidtetO HAC Loss
Targeting of the transcriptional transactivator tTA to the
alphoidtetO HAC produced a mosaic response in which the
HAC kinetochore was inactivated in some cells, but not in others.
In a ‘‘cell-by-cell’’ assay, we transfected cells bearing the
alphoidtetO HAC with various plasmids, killed the nontransfected
cells with puromycin, and scored the percentage of cells bearing
0, 1, or 2 copies of the HAC (detected by FISH with the BAC
probe; Figure 3A) after 11–12 d. To control for effects of the
transfection procedure on HAC stability, all values were normal-
ized to those for cells transfected with plasmid carrying only a
puromycin resistance cassette.
Transfection of cells with plasmids expressing tetR-EYFP had
essentially no effect on HAC stability (Figure 3A). In contrast, tTA
expression caused a reproducible increase in the population of
cells lacking the HAC (Figure 3A). Transfection with tTA3 (39%
as active as tTA in promoting transcription) or tTA4 (14% activity)
also caused significant, albeit reduced, levels of HAC loss. The
tTA had no effect on HAC stability if cells were grown in the pres-
ence of doxycycline.
In a quantitative population assay, AB2.2.18.21 cells were in-
fected with retroviral vectors expressing the tTA, and the copy
number of alphoidtetO dimer in selected clones was quantitated
30 d later by real-time PCR. Cells infected with control vectors
expressing the marker gene or tetR alone showed no increase
in HAC instability (Figure 3B). Cultures expressing the tTA
showed a 6-fold increase in the rate of HAC loss (27% decrease
in HAC content). No significant HAC loss was observed in
parallel cultures grown in doxycycline (Figure 3B).
tTA expression caused a mosaic pattern of alphoidtetO HAC
loss in clonal cell lines after culturing for 37 d without selective
drug (Figure S5). Chromosome loss rates were remarkably high
in 43% (10/23) of cell lines, but were either moderate or normal
in the remaining cell lines. In controls, expression of mRFP-
tetR had a minimal effect on the stability of the alphoidtetO
HAC, and expression of the tTA or mRFP-tetR had no effect on
loss rates for endogenous chromosomes X or 17, thereby con-
firming that chromosome loss induced by tTA expression was
specific for the alphoidtetO HAC.
tTA expression caused a 2-fold increase in the very low level
of alphoidtetO transcripts, but had no effect on the much higher
levels of transcription from the bsr gene (Figure 4E). However,
examination of the HAC chromatin following tTA expression
failed to reveal significant structural differences detected by
ChIP with antibodies to H3K4me2 or H3K4me3 (data not shown).
This is most likely because tTA binding to the HAC elicits a mo-
saic response, in which a minority of cells respond by increasing
transcription, and destabilizing the HAC (Figures 4B and 4E and
Figure S5B0). Since the HAC appears to resist effects caused by
tTA binding in most cells, this could explain why the chromatin
changes analyzed by ChIP remain below our limit of detection.
These experiments demonstrate that the alphoidtetO HAC ki-
netochore can be inactivated in a subset of cells by targeting its
chromatin with a transcriptional activator. If, indeed, kinetochore
inactivation is induced by transcription of the alphoidtetO array,
this result might be similar to that observed in budding yeast,
where strong transcriptional bombardment can inactivate a con-
ditional centromere (Hill and Bloom, 1987). What was more sur-
prising was that a transcriptional silencer had a much stronger
effect and appeared to completely inactivate the kinetochore.
Binding of the tTS Silencer Induces Dramatic
AlphoidtetO HAC Loss
The tTS, a powerful transcriptional repressor, induced a highly
penetrant destabilization of the HAC (Figures 3A and 3B). The
Figure 3. Targeting a Transcriptional Activator or Silencer into the HAC Kinetochore Induces HAC Loss
(A) The HAC cell-by-cell stability assay. Coding regions of proteins to be tested were cloned into a vector that also expresses a puromycin resistance marker.
Nontransfected cells were killed by puromycin and the remaining population was analyzed by FISH to quantify the HAC retention after 11–12 d of culture. To
correct for variability in transfection and killing efficiency, all values were normalized to the results of transfection with empty vector bearing puromycin resistance
(gray bars in lower panel). Lower panel: expression of transcriptional activators (tTA, tTA3, tTA4) and silencer tTS causes significant destabilization of the HAC
with efficiency tTS > tTA > tTA3,tTA4 (n = 2–5). Constructs yielding results indistinguishable from the control have a value on the ordinate of 1.0. Addition of doxy-
cycline, which prevents TetR from binding TetO, blocked the inactivation of HAC kinetochore by tTA and tTS (shaded bars).
(B) Quantitative HAC stability assay using real-time PCR. The proteins to be tested were expressed using retroviral vectors. Virus-infected cells were maintained
in medium containing neomycin ± doxycycline. After 30 d postinfection (left panel) (or additionally, 7 or 14 d for tTS or tTS mutant expressing cells, middle and
right panels), the relative copy number of the alphoidtetO array was quantitated by real-time PCR. Numbers above the bars indicate the HAC loss rate (R) calcu-
lated using the formula: N30 = N0 3 (1R)30. Asterisk indicates HAC loss rate between 7 and 14 d after tTS binding. Cells expressing the tetR protein (tetR) or
infected with empty vector (pFB-Neo) showed no HAC instability after 30 d of culture. The KAP-1 interaction deficient mutant (tTS mutant, right blue bars) failed
to induce HAC instability over 14 d. Error bars indicate SD (n = 3).
(C and C0 ) The HAC (detected by FISH, green in [C0]) fails to segregate with the bulk chromosomes (stained with DAPI, grayscale in [C], blue in [C0]) in anaphase
cells expressing the tTA transactivator. Size bar = 5 mm.
(D and D0) Nanonucleus revealed by DAPI staining (D) contains the HAC (D0), as revealed by FISH with the BAC probe (colors as in [C0]). HACs are indicated by
arrows.
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Figure 4. TetR-Fusion Proteins Specifically Associate with the AlphoidtetO Array and Change Its Transcriptional Activity
(A) AB2.5.30 cells containing a stably integrated alphoidtetO dimer array and expressing tetR-EYFP, tTA-EYFP, or tTS-EYFP were cultured in doxycycline-free
medium for 14 d and analyzed by ChIP using anti-GFP (binds EYFP). Bars show the relative enrichment of various target DNA loci.
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tTS is a fusion of the tetR and the Kruppel-associated box
(KRAB)-AB silencing domain of the Kid-1 protein (kidney, ische-
mia, development; Witzgall et al., 1994; Freundlieb et al., 1999).
Unlike the variable and weak effects seen following expression
of the tTA, AB2.2.18.21 cells showed a 72-fold increase in the
rate of HAC loss (97% decrease in HAC content) 30 d after infec-
tion with retroviral vectors expressing the tTS (Figure 3B). HAC
loss was essentially complete by 14 d of tTS expression. This ef-
fect of the tTS was also seen in the ‘‘cell-by-cell’’ protocol of
Figure 3A. Expression of a tTS point mutant (tTSmut) unable to
bind the corepressor KAP-1 (KRAB-associated protein-1; Agata
et al., 1999; Matsuda et al., 2001) had no effect on alphoidtetO
HAC stability even after 14 d (Figure 3B). Thus, destabilization
of the HAC by the tTS apparently occurs via the KAP-1 pathway.
In control experiments, we determined that the differential ef-
fects of tetR-EYFP, tTA, and tTS on HAC stability could not sim-
ply be explained by differences in the affinity of these proteins for
the alphoidtetO array. In ChIP experiments, tetR-EYFP appeared
to bind to the alphoidtetO array slightly more efficiently than did
tTA-EYFP and tTS-EYFP (Figure 4A). The three proteins ex-
hibited similar levels of binding to the HAC in vivo as measured
by quantitative fluorescence (Figures 4B and 4C). However, in
some cells, HACs with bound tTA-EYFP appeared to be larger,
and had higher levels of associated FP. Importantly, the tTS,
which dramatically destabilized the HAC, bound to it at levels
comparable to the tetR, which had no observable effect on
HAC stability.
The tTS Disrupts CENP-A Kinetochore Chromatin
tTS binding to the alphoidtetO array converted the centromeric
chromatin to a more heterochromatic state, disrupting the
CENP-A kinetochore domain (Figures 4 and 5). This conversion
was accompanied by dramatic reduction of levels of alphoidtetO
transcription detected by quantitative RT-PCR (Figure 4E). tTS
binding caused a rapid loss of H3K4me2 and somewhat slower
decrease in CENP-A levels on the alphoidtetO array (Figure 5). We
also observed a transient increase in H3K9me3 levels. In con-
trols, binding of tetR to the alphoidtetO HAC caused no detect-
able changes in the HAC chromatin.
tTS binding also reduced H3K4me2 and H3K4me3 levels and
increased H3K9me3 levels on the marker gene as well as
strongly repressing its transcription (Figures 4 and 5). Thus, the
closed chromatin structure induced by tTS binding spreads lat-
erally to the BAC vector region. Furthermore, although only 4%
of the HAC DNA remained in the population at later times, the
fact that H3K9me3 levels remained high on the marker gene
while dropping on alphoidtetO DNA suggests that even after
tTS binding, subtle differences in chromatin structure remain
between the (now inactive) kinetochore and flanking regions.
Kinetochore Inactivation Leads to HAC Loss
by Nondisjunction and Formation of Nanonuclei
The tTS induces HAC loss by disrupting kinetochore structure. If
AB2.2.18.21 cells expressing tTS-EYFP were cultured in doxy-
cycline-free medium for 7–8 d to allow tTS binding to the kineto-
chore, the CENP-A, CENP-B, and CENP-C signals on HACs with
associated FP signals were either undetectable or significantly
weaker than those on endogenous centromeres (Figures 6, 7B,
and 7G and Figure S6C). AlphoidtetO HACs lacking detectable
CENP-A were observed in 34% of interphase cells and 39% of
mitotic cells (Figures 6E and 6F). In those cells, the FP signal
overlapped with significant levels of H3K9me3, a marker for het-
erochromatin that was not enriched on HACs targeted by tetR-
EYFP (Figures 7C and 7D). In parallel control experiments,
tetR-EYFP colocalized with CENP-A and CENP-C on the
alphoidtetO HAC, confirming that this protein does not disrupt
kinetochore structure (Figures 6E and 7A, and Figures S6A
and S6B).
In cells expressing the tTA, we frequently observed that one or
both copies of the HAC was spatially separate from the other
chromosomes during mitosis (Figure 3C). Similarly, when
AB2.2.18.21 cells were examined after 7–8 d of tTS-EYFP ex-
pression, we saw HACs with FP signals lying outside the mass
of congressed chromosomes in 28% of mitotic cells (Figures
6A, 6D, and 6F). These nonaligned HACs lacked detectible kinet-
ochore proteins, including CENP-A, CENP-B, and CENP-C.
Loss of the alphoidtetO HAC induced by the various forms of
tTA and tTS could occur by two mechanisms: nondisjunction
(2:0 segregation) or chromosome loss (failure to replicate , 1:0
segregation). All of our assays revealed that the increase in cells
with no HAC was not balanced by a corresponding increase in
cells with two HACs. (Note that the cell-by-cell assay scores
only HAC signals in the nucleus. See below.) Thus, the HAC ini-
tially appeared to be undergoing chromosome loss. However,
(A0) AB2.2.18.21 cells bearing the alphoidtetO HAC and expressing tetR-EYFP and tTS mutant (tTSmut)-EYFP were cultured in doxycycline-free medium for
14 d and analyzed by ChIP with anti-GFP. The bars show the relative enrichment of various target DNA loci by ChIP. All tetR-fusion proteins specifically bound
to the alphoidtetO DNA in a doxycycline-dependent manner.
(B and C) Quantitative analysis of the fluorescence intensity of various tetR-EYFP constructs bound to the HAC. Transfected cells were analyzed using a Delta-
Vision microscope under identical acquisition conditions.
(B) The raw fluorescence intensity of the tetR-EYFP constructs is shown (n = 9–10), together with representative images. Size bar = 5 mm.
(C) The fraction ‘‘enriched’’ on the HAC was calculated by normalizing for the unbound nucleoplasmic fraction. In some cells, the amount of tTA bound was
relatively higher. In these cells, the HACs also appeared larger (insets in [B]), possibly because they contain more decondensed chromatin.
(D) Mitotic cells with tTS-EYFP bound to the HAC. The presence of two sister chromatids confirms that the HAC had replicated in the previous S phase. Arrow-
heads indicate the HAC.
(E) Levels of transcripts derived from the alphoidtetO HAC were analyzed by quantitative RT-PCR using total RNA purified from AB2.2.18.21 cells expressing tetR,
tTA, or tTS. Cells were cultured in doxycycline-free medium for 3, 7, 10, and 14 d. The bars show the transcription levels of alphoidtetO dimer (left panel) or bsr gene
(right panel) relative to that of the negative control, which contains no reverse transcriptase in the reaction mixture (dashed line on left panel). Levels of each tran-
script were corrected for the copy number of alphoidtetO HAC as determined by quantitative PCR using the genomic DNA of each cell line and normalized by that
of endogenous alphoidchr.21 (for alphoidtetO) or human b-actin (for bsr gene). The levels of transcripts from alphoid DNA were extremely low (2.9-fold above the
reverse transcriptase free control reaction for alphoidchr.21) compared to those from the bsr gene (1,500 fold) and b-actin (19,000 fold). Error bars indicate SD
(n = 2).
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the fact that tetR-EYFP had no effect on HAC stability suggested
strongly that tetR binding to the alphoidtetO array does not inter-
fere with HAC replication, and that loss must be occurring via
another mechanism. This is consistent with data shown in
Figure 4D in which a HAC with bound tTS is present as two
replicated sister chromatids in mitosis.
Detailed examination of cultures revealed that cells expressing
either the tTA or tTS often had minute DAPI-stained structures in
the cytoplasm (Figures 3D, 6B, 6C, and 6E and Figure S6E).
These resemble tiny versions of micronuclei typically observed
when chromosomes fail to segregate correctly in mitosis,
and we refer to them as nanonuclei. After 7 d of tTS expression,
11% of interphase cells had nanonuclei containing the
alphoidtetO HAC (Figures 6B, 6C, 6E, and 6F and Figure S6E).
Nanonuclei lack detectible ACA, CENP-A, or CENP-B staining,
indicating that they do not contain functional kinetochores.
Although detailed characterization of nanonuclei is beyond the
scope of this study, we suspect that sequestration of the
alphoidtetO HAC in these tiny structures ultimately results in its
loss from the population.
Together these results indicate that targeting of chromatin-
modifying activities into the alphoidtetO kinetochore disrupts
centromere chromatin, evicting CENP-A, CENP-B, and other
kinetochore proteins, and ultimately inactivating the kinetochore.
HP1a Recruited by the tTS Can Inactivate
the Kinetochore
tTS binding to the alphoidtetO array could in theory inactivate the
kinetochore by a number of pathways, including the formation of
heterochromatin involving H3K9me3 and HP1a. We therefore
stained HAC-bearing cells for HP1a following exposure to tetR,
the tTA, and the tTS (Figure 7). Of these treatments, only the
tTS induced a robust accumulation of HP1a at the kinetochore
(Figures 7G00 and 8D). This accumulation was accompanied by
disruption of the kinetochore, as detected by the loss of
CENP-C staining.
To test whether the accumulation of HP1a was sufficient to
disrupt kinetochore structure, we fused tetR-EYFP to HP1a,
thereby targeting the heterochromatin protein by a mechanism
independent of core histone modifications. Strikingly, this di-
rected targeting of tetR-EYFP-HP1a to the alphoidtetO repeats
was sufficient to disrupt kinetochore structure, as determined
by the loss of CENP-C staining (Figure 8B). When cells were
scored for the loss of CENP-C staining, the tTS and HP1 were
found to yield a comparable effect (Figure 8C). Targeting of
HP1a to the alphoidtetO array did not block replication of the
HAC, as detected by the presence of two paired sister chroma-
tids (Figure 8B), but did destabilize the HAC (S.C., Jan Berg-
mann, M.N., Marcella Cervantes, V.L., H.M., and W.C.E., unpub-
lished data). All these results suggest that HP1a recruitment may
be sufficient to account for the action of the tTS and that the
nucleation of heterochromatin within the array is sufficient to
inactivate the kinetochore.
DISCUSSION
We have developed a novel human artificial chromosome (HAC)
to manipulate for the first time, to our knowledge, the epigenetic
status of a single human kinetochore. The HAC was based on
a synthetic repeated DNA sequence, the alphoidtetO dimer. One
part of this dimer is a natural human alphoid monomer from chro-
mosome 17 containing a CENP-B box. The other has no known
counterpart in the natural human genome, and contains a
42 bp tetracycline operator (tetO) in place of the CENP-B box.
The kinetochore of the alphoidtetO HAC is functionally indistin-
guishable from the kinetochore of endogenous chromosomes. It
binds several key markers for centromeric chromatin, including
CENP-A, CENP-C, and CENP-H, as well as H3K4me2. It appar-
ently also contains some normal heterochromatin associated
with H3K9me3 and INCENP. Most importantly, the alphoidtetO
HAC exhibits normal behavior in mitosis and normal stability in
long-term culture.
The tetO sequences within the active kinetochore of the al-
phoidtetO HAC remain accessible to tetracycline repressor (tetR).
Furthermore, targeting of mRFP or EYFP into the kinetochore as
tetR fusions had at most a minimal effect on HAC stability. How-
ever, targeting of the tTA transcriptional activator or tTS transcrip-
tional repressor inactivated the HAC kinetochore. Thus, this HAC
is, to our knowledge, the first chromosome outside of budding
yeast (Hill and Bloom, 1987) with a conditional centromere.
Inactivation of the Kinetochore by a Transcriptional
Activator
Targeting of the tTA to the alphoidtetO array inactivates the kinet-
ochore in some cells. The VP16 transactivation domain of the tTA
can directly interact with several general transcription factors in-
cluding the TATA-binding protein (TBP), TFIIB, and the SAGA
histone acetylase complex in vivo (Hall and Struhl, 2002; Klein
et al., 2003; Herrera and Triezenberg, 2004). tTA inactivation of
the kinetochore could involve either transcriptional activation,
or simply induction of a transcriptionally competent open
chromatin structure around its binding site (Figure 8E).
The tTA appeared to destabilize the HAC in some cells but not
in others, resulting in a less potent effect overall on HAC stability
than the tTS. We have considered two explanations for this. First,
CENP-A chromatin may be able to resist transcriptional activa-
tion by the tTA. Alternatively, CENP-A chromatin may tolerate
a degree of chromatin ‘‘opening’’ while retaining kinetochore
activity. The presence of actively transcribed genes within rice
centromeres (Nagaki et al., 2004) and human neocentromeres
(Saffery et al., 2003), plus the detection of low level transcription
of alphoid sequences in humans (Figure 4E) or in DT40 cells with
a human chromosome (Fukagawa et al., 2004), suggest that in
many cases, functional kinetochores can contain ‘‘open’’ chro-
matin. Possibly, low levels of transcription are tolerated within ki-
netochore chromatin, however high level transcription triggered
by a stochastic event occurring in a subset of cells expressing
Figure 5. tTS-Enhanced Heterochromatin Assembly and CENP-A Chromatin Disassembly on the AlphoidtetO HAC
AB2.2.18.21 cells expressing tetR or tTS were cultured in doxycycline-free medium for 7 or 14 d and analyzed by ChIP with antibodies against CENP-A and mod-
ified histone H3. CENP-A assembly on alphoidtetO dimer was gradually decreased following induction of tTS binding for 7–14 d. Levels of H3K4me2 and H3K4me3
on the alphoidtetO HAC decreased rapidly upon tTS binding. In contrast, H3K9me3 levels on the alphoidtetO HAC increased transiently following tTS binding, but
then declined again (possibly due to loss of the HAC). Error bars indicate SD (n = 2–3).
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the tTA may disrupt kinetochore function. It has long been known
that bombardment with transcription from a strong promoter can
inactivate a yeast kinetochore (Hill and Bloom, 1987).
Heterochromatin Is Incompatible
with Kinetochore Function
The tTS was a significantly stronger disruptor of kinetochore
function than the tTA (Figure 8E). The tTS can recruit the scaffold-
ing protein KAP-1 (Friedman et al., 1996), which in turn recruits
Figure 6. tTS Targeting to the AlphoidtetO HAC Induces Lagging Chromosomes and Formation of Nanonuclei
AB2.2.18.21 cells were either transiently transfected with constructs expressing the tTS ([A], [B], and [D]) or AB2.2.18.21 cells stably expressing the tTS (C) were
incubated in the absence of doxycycline to allow TetR binding to the tetO sequences in the alphoidtetO HAC. EYFP (green) was detected either via its own fluo-
rescence ([A], [B], and [D]) or using an anti-GFP antibody (C). Cells were also stained for CENP antigens with ACA (red in [A0 and B0]), anti-CENP-A antibody (red,
[C0]), or anti-CENP-B antibody (red, [D0]). Chromosomes were stained with DAPI (blue, [A00–D00]). Nonaligned alphoidtetO HACs targeted by tTS-EYFP were ob-
served in mitotic cells (A and D). These HACs lacked detectible CENP-A, -B, and -C. In interphase cells, nanonuclei with associated tTS-EYFP were observed
([B], [C], and [E]). Nanonuclei also lacked detectible CENP-A and ACA antigens. Arrows indicate the HACs. Bar = 10 mm. (E) AB2.2.18.21 cells with alphoidtetO HAC
expressing tetR (upper panels) or tTS (middle and lower panels) were cultured in doxycycline-free medium for 7 d and analyzed by immuno-FISH using anti-
CENP-A antibody (green) and BAC vector probe (red). DNA was stained by DAPI (blue). Arrowheads indicate the alphoidtetO HAC. In tTS expressing cells, lagging
HACs (middle right) and nanonuclei (lower left) were observed in mitosis and interphase, respectively. (F) Nanonuclei or lagging HAC were frequently observed in
tTS-expressing cells (red bars, n > 50).
Figure 7. tTS Binding Induces Heterochro-
matin Formation and Kinetochore Disas-
sembly on the AlphoidtetO HAC
(A–D) AlphoidtetO HAC cell lines expressing tetR-
EYFP (A and C) or tTS-EYFP (B and D) were
cultured in doxycycline-free medium for 8 d and
analyzed by indirect immunofluorescence using
anti-GFP (green, [A–D]) and anti-CENP-A (red, [A0
and B0]) or anti-H3K9me3 (red, [C0 and D0]). DNA
was stained by DAPI (blue, [A00–D00]). The HAC is in-
dicated by arrows. Bar in (D00 0) = 10 mm for (A–D).
(E) tetR-EYFP has no effect on kinetochore struc-
ture and does not recruit HP1a.
(F) tTA-EYFP inactivates the kinetochore, as
shown by loss of CENP-C, but does not recruit
HP1a.
(G) The tTS inactivates the kinetochore, accompa-
nied by a robust recruitment of HP1a. Bar in (G00 0) =
5 mm for (E–G).
chromatin modification factors including
Mi-2a— a core component of the NuRD
histone deacetylase complex (Schultz
et al., 2001), SETDB1—the histone H3
Lys9 selective methyltransferase (Schultz
et al., 2002), and heterochromatin protein
1 isoforms (Nielsen et al., 1999; Ryan
et al., 1999; Lechner et al., 2000). In
controls, a tTS point mutant unable to
interact with KAP-1 did not destabilize
the alphoidtetO HAC, suggesting that re-
cruitment of KAP-1 can lead to inactiva-
tion of the alphoidtetO kinetochore. We
will report elsewhere a detailed analysis
of the role of the various KAP-1 domains
in kinetochore inactivation (S.C., Jan
Bergmann, M.N., Marcella Cervantes,
V.L., H.M., and W.C.E., unpublished
data).
tTS disruption of the kinetochore is unlikely to be a passive by-
product of the recruitment of bulky chromatin remodeling com-
plexes onto the alphoidtetO array. We have shown that a variety
of proteins, including tTSmut can be recruited into the alphoidtetO
kinetochore without having any detectable effect on its function.
Furthermore, it is important to note that the tTA also recruits
a different spectrum of chromatin remodeling complexes into
the kinetochore, yet has a much milder effect on kinetochore
function.
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Figure 8. HP1a Recruitment Inactivates the AlphoidtetO Kinetochore
(A) A duplicated HAC at metaphase has bound tetR-EYFP and CENP-C.
(B) A duplicated HAC at metaphase has bound tetR-EYFP-HP1a, but lacks CENP-C. Bar in (B0) = 5 mm for (A and B).
(C) Quantitation of the effects of expression of tetR-EYFP, tetR-EYFP-HP1a, and tTS-EYFP on the levels of CENP-C at kinetochores.
(D) AB2.2.18.21 cells expressing tetR or tTS were cultured in doxycycline-free medium for 7 or 14 d and analyzed by ChIP with anti-HP1a antibody. The tTS in-
duces targeting of HP1a to both the alphoidtetO array and the adjacent marker gene. The decrease seen at 14 d likely reflects loss of the HAC. Error bars indicate
SD (n = 2–3).
Developmental Cell
Conditional Human Centromere
Developmental Cell 14, 507–522, April 2008 ª2008 Elsevier Inc. 519
It appears that the tTS inactivates the alphoidtetO kinetochore
by nucleating the formation of classical heterochromatin con-
taining H3K9me3 and HP1. In a previous study, binding of
a KAP-1 fusion protein to a targeted transgene reduced levels
of histone H3K9 acetylation and H3K4 methylation, and in-
creased H3K9me3 levels at the site (Sripathy et al., 2006).
Here, we found that tTS binding decreased H3K4 methylation,
increased H3K9me3 levels, and induced HP1 accumulation
within the alphoidtetO kinetochore. This heterochromatin-like
state spread onto the flanking marker gene, which had previ-
ously been in an open, actively transcribing state. In fact, we
found that targeting of HP1 directly as a fusion to tetR-EYFP
was sufficient to inactivate the kinetochore. This rules out the
necessity of other activities of the tTS or KAP-1 in kinetochore
inactivation.
Although it was long taken for granted that centromeres were
heterochromatic, recent cytological observations have sug-
gested that this might not be the case (Schueler and Sullivan,
2006). In addition, it has been observed that overexpressed
CENP-A does not incorporate into heterochromatin (Vermaak
et al., 2002), and in Drosophila, heterochromatin can block neo-
centromere formation (Maggert and Karpen, 2001). The experi-
ments shown here demonstrate for the first time, to our knowl-
edge, that targeted nucleation of heterochromatin within the
kinetochore abolishes the binding of the centromere specific his-
tone H3, CENP-A, and inactivates a fully functional kinetochore.
Although the detailed mechanism remains to be determined, we
have considered three ways in which heterochromatin formation
could evict CENP-A from the alphoidtetO array. First, the confor-
mation of chromatin fibers containing HP1 might be inconsistent
with the relatively rigid structure proposed for CENP-A-contain-
ing chromatin (Black et al., 2004). In other studies, we have found
that formation of H3K9me3 chromatin prevented CENP-A
assembly on an ectopically integrated cluster of short alphoid
DNA arrays (Okamoto et al., 2007), provided that CENP-B is
present (Okada et al., 2007).
Alternatively, tTS binding leads to a rapid drop in the levels on
the alphoidtetO array of H3K4me2, which has recently been de-
scribed as a marker for centromere chromatin (Sullivan and
Karpen, 2004). This drop, which is balanced by a temporary in-
crease of H3K9me3 levels, appears to slightly precede the loss
of CENP-A from the alphoidtetO array. This raises the possibility
that H3K4me2, possibly together with other core histone modifi-
cations, could have an essential role in helping to maintain the
structure of centromere chromatin.
Finally, heterochromatin assembly might inactivate the
alphoidtetO kinetochore by suppressing the (low) level of endog-
enous transcription of the array. Although evidence for RNAi
involvement in vertebrate chromosome segregation is scant
(Fukagawa et al., 2004; Kanellopoulou et al., 2005), RNAi has
a clear role in establishment of the flanking heterochromatin at
S. pombe kinetochores (Grewal and Jia, 2007).
Until now, the chromatin configuration of active kinetochores
has been the subject of careful observation and intense specula-
tion (Sullivan and Karpen, 2004), but has remained inaccessible
to direct targeted manipulation. In addition to providing a clear
demonstration that experimentally induced heterochromatin
within the centromere is incompatible with kinetochore activity,
our studies reveal that the remarkable dynamism of the chroma-
tin within the kinetochore of the alphoidtetO HAC should allow
the systematic manipulation of the ‘‘histone code’’ within the
kinetochore and definition of the full epigenetic signature of
centromere chromatin.
EXPERIMENTAL PROCEDURES
Standard procedures, including descriptions of cell lines, the BAC transfection
protocol, analysis of de novo HAC formation analyses by fluorescence in situ
hybridization (FISH), construction of tetR-fusion proteins expression vectors,
Chromatin immunoprecipitation (ChIP), real-time PCR, and indirect immuno-
fluorescence are discussed in the Supplemental Experimental Procedures.
Construction of tetO Dimer Alphoid BACs
The alphoidtetO monomer sequence was assembled by coligation of five dou-
ble-stranded oligomers and cloned into pBluescript using the XhoI/SalI sites.
A naturally occurring alphoid monomer (168 bp) containing a consensus
CENP-B box was isolated from p17H8 (Waye and Willard, 1986). The 2.7 kb
higher-order repeat was digested with BsmI and the appropriate DNA frag-
ment was isolated after agarose gel electrophoresis. The fragment was
blunt-ended with T4 polymerase and cloned into the SmaI site of pBluescript.
After amplification of the monomer by PCR to introduce SalI and XhoI sites, it
was inserted into pBluescript next to the tetO monomer.
Subsequent cycles of digestion and cloning the XhoI/SalI site of pBluescript
yielded p3.5a, containing 10 alphoidtetO dimer fragments (Figure 1A). The ex-
tension of the tetO dimer alphoid repeat was carried out by rolling-circle am-
plification (RCA) for the circularized template of the alphoidtetO 10-mer excised
from p3.5a, using f29 DNA polymerase. Resulting RCA products were cloned
into a targeting vector in yeast by transformation-associated homologous re-
combination (TAR) according to previously described methods (Ebersole et al.,
2005). The targeting vector (RSA/SAT43) contains YAC (HIS3, CEN6, ARSH4)
and BAC (Cm, ori F) cassettes as well as a mammalian selectable marker (bsr).
Purified genomic DNA from the yeast clones was electroporated into
Escherichia coli cells (DH10B, Invitrogen). The insert size of the synthetic
alphoidtetO DNA array was analyzed by PFGE (CHEF, Bio-Rad) after NotI
digestion of BAC DNA.
The Analysis of HAC Loss Rate, R, in the TetR-Fusion Protein
Expressing Cells with Real-Time PCR
AB2.2.18.21 cells expressing tetR, tTA, and tTS fusion proteins were con-
structed by retroviral vector gene expressing system. Infected cells were
treated by geneticin and/or 1 mg/ml of doxycycline for 30 d (and 7 or 14 d for
tTS expressing cell). The genomic DNAs of each cell lines were purified using
DNeasy Tissue Kit (QIAGEN) according to the manufacturer’s instructions. Pu-
rified genomic DNAs were sonicated (Bioruptor sonicator, Cosmo Bio, Japan)
for 3 min. One hundred nanograms of genomic DNA was used for analysis by
(E) Inactivation of the kinetochore by modulating the epigenetic status of the underlying chromatin. Centromere chromatin containing CENP-A (red) and H3K4me2
(not shown here) assembles on the alphoidtetO dimer array of the HAC, forming an active kinetochore structure. The chromatin of the marker gene contains
H3K4me3 (green). Binding of the tTS (tetR-SDkid-1) induces H3K9 trimethylation (blue) at its target sites (red rectangle and arrow) on the alphoidtetO HAC. The
resulting remodeling and compaction of the chromatin is incompatible with the structure of CENP-A chromatin and CENP-A quickly disappears from the hetero-
chromatic alphoidtetO array. The centromere/kinetochore is inactivated. tTA (tetR-VP16) binding induces formation of open chromatin at the target site. In some
cases, the open chromatin structure (euchromatin) somehow disrupts the CENP-A chromatin. However, in the case of tTA, the degree of HAC inactivation was
less than that seen with the tTS. This suggests that the core of CENP-A chromatin is less sensitive to chromatin opening induced by VP16 and that in many cases
HACs with open chromatin can still maintain a functional kinetochore. The data presented suggest an epigenetic mechanism to regulate the kinetochore activity
based in part upon antagonism between centromere chromatin rich in CENP-A and H3K4me2 and heterochromatin rich in H3K9me3.
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real-time PCR with primers tet-1 and tet-3 using the iCyclerIQ MultiColor
Real Time PCR Systems (Bio-Rad). The following primer sets were used:
5SDNA-F1 and 5SDNA-R1 for 5S ribosomal DNA, and tet-1 and tet-3 for the
alphoidtetO dimer.
Analysis by FISH of the HAC Loss Rate, R, in Cells
Expressing Cells TetR-Fusion Proteins
Cells were transfected with Lipofectamine 2000 (Invitrogen) at 90% conflu-
ence and after 24 hr puromycin was added to the medium at a concentration
of 1.5 mg/ml. After 24–30 hr the medium was changed and the cells incubated
for 4 d before being selected again with the same concentration of Puromycin
for 24–30 hr. After the second selection, cells were incubated in fresh
medium for 5 d, plated on poly-lysine-coated slides and processed for fluores-
cence in situ hybridization (FISH) using a BAC-based probe. The slides, fixed
with Carnoy’s fixative, were left to age overnight. The probe was denatured for
5 min at 95C and added to the slides, which were incubated at 72C for 2 min
before overnight incubation at 39C. After washes with 0.13SSC (203SSC: 3
M NaCl, 0.3 M NaCitrate) at 65C followed by a wash with 4 3 SSC + 0.1%
Tween20 at RT, slides were incubated (with intervening washes), successively,
with FITC-avidin, biotinylated-anti-avidin, and FITC-avidin. Slides were
mounted with VectaShield.
SUPPLEMENTAL DATA
Supplemental Data include seven figures, two tables, Supplemental Experi-
mental Procedures, and Supplemental References and can be found with
this article online at http://www.developmentalcell.com/cgi/content/full/14/4/
507/DC1/.
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